Pharmaceutical composition for treating HBsAg, HBeAg, and HBcAb test positive, HBsAg, HBeAb, and HBcAb test positive, liver cirrhosis and liver ascites

Abstract

The invention discloses a pharmaceutical composition for treating treating HBsAg, HBeAg, and HBcAb test positive, HBsAg, HBeAb, and HBcAb test positive, liver cirrhosis and liver ascites. The pharmaceutical composition is prepared from the following raw materials of 15-20 g of oldenlandia diffusa, 15-20 g of scutellaria barbata, 15-20 g of blackberry lily, 25-30 g of damnacanthus indicus, 35-40 gof polygonum cuspidatum, 25-30 g of gardenia jasminoides and 25-30 g of cudrania cochinchinensis. The pharmaceutical composition has the functions of promoting diuresis, removing jaundice, clearing away heat and toxic materials, promoting blood circulation, removing blood stasis, relieving pain, reducing phlegm, stopping coughing, promoting blood circulation, resisting cancer, killing bacteria, enhancing immunity and repairing normal liver metabolism.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicine, in particular to a pharmaceutical composition for treating large and small three yang, liver cirrhosis and hepatic ascites. Background technique [0002] Liver cirrhosis is liver damage caused by a variety of reasons. The liver is progressive, diffuse, and fibrous. The specific manifestation is diffuse degeneration and necrosis of liver cells. Fibrous tissue hyperplasia and nodular regeneration of liver cells followed, and these three changes were repeated and interlaced, resulting in the gradual remodeling of the liver lobular structure and blood circulation pathways, causing the liver to deform and harden. In the later stage, complications such as portal hypertension, ascites, liver dysfunction, upper gastrointestinal bleeding, and hepatic coma appear, and the prognosis is poor. Cirrhotic ascites is a decompensated disease. The condition is complicated, the treatment is difficult, a...

AI Technical Summary

Problems solved by technology

[0008] Hepatitis B is a virus in the viscera. The function of this disease is low, the pathogenesis is complicated, the course of the disease is long, it is easy to repeat, and it is affected by genetic medicine. Diseases caused by heat in the blood are difficult to cure. At present, there are many products in Western medicine and Chinese patent medicines for the treatment of hepatitis B, large and small, and three yang, but the cure rate is generally not enough. The treatment does not fully regulate the overall disease resistance and the effect of blood in removing heat and toxins. Symptoms, not root cause